The Latest Cardiac and Vascular News
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) — Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the closing of its previously announced initial public offering of 16,141,157 shares of its common stock, which includes 2,105,368 shares […]
Leading ECG analysis platform speeds time to diagnosis and creates greater clinical efficiencies with expanded software capabilities BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc. (“Cardiac Insight” or the “Company”) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to improve early detection and […]
BOSTON–(BUSINESS WIRE)–Imbria Pharmaceuticals, a clinical stage biopharmaceutical company developing novel therapies designed to enhance cellular energetics for the treatment of major forms of heart disease and specific inborn errors of metabolism, today announced that the first 10 (ten) patients were dosed in the IMPROVE-DiCE Phase 2a, open-label study of IMB-1018972 […]
Charlottesville, VA June 22, 2021 – Caretaker Medical, developer of the Caretaker™ Wireless Hemodynamic Patient Monitor has been selected for MedTech Innovator’s Annual Showcase and Accelerator for 2021. Caretaker Medical was selected from a field of over 1100 companies across 50 countries as one of the Top 50 MedTech firms […]
Novel Biodegradable Stent Technology Approved for Sale in Europe WINSEN, Germany, June 21, 2021 /PRNewswire/ — QualiMed Innovative Medizinprodukte GmbH, a wholly owned subsidiary of Dublin, Ireland based Q3 Medical Devices Limited (Q3), announced that it has received CE mark approval for a dedicated percutaneous biodegradable metal alloy based stent implant for biliary applications, the UNITY-B Percutaneous Balloon […]
PARIS–(BUSINESS WIRE)–Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today that it has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for its Clotild® Smart Guidewire System designed […]
– First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy – Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia Recurrence DUBLIN, June 21, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it received U.S. Food and Drug […]
Dr. Azeem Latib and Doug Teany join to bring deep subject matter expertise in coronary and structural heart procedures as well as robotic surgery CLEVELAND, June 21, 2021 /PRNewswire/ — Centerline Biomedical, Inc. (Centerline), a spinoff of Cleveland Clinic, today announced the appointment of two key advisors. As Centerline launches its flagship Intra-Operative […]
Leading provider of wearable device-derived health data partners with vascular health-tech firm to provide industry-leading health insights for clinical and other users ATLANTA, June 21, 2021 /PRNewswire/ — LifeQ, the world’s preeminent provider of biometrics and health information derived from wearable devices, has partnered with CONNEQT, Inc, a consumer health company offering home […]
SAN CARLOS, Calif., June 21, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that the European patent office has issued a Decision to Grant European Patent No. 3593810 to BioCardia with publication on June 23, 2021. […]
